313 related articles for article (PubMed ID: 24897928)
1. The impact of HAART initiation timing on HIV-TB co-infected patients, a retrospective cohort study.
Yang CH; Chen KJ; Tsai JJ; Lin YH; Cheng SH; Wang KF; Chiou HY
BMC Infect Dis; 2014 Jun; 14():304. PubMed ID: 24897928
[TBL] [Abstract][Full Text] [Related]
2. Factors impacting early mortality in tuberculosis/HIV patients: differences between subjects naïve to and previously started on HAART.
Schmaltz CA; Santoro-Lopes G; Lourenço MC; Morgado MG; Velasque Lde S; Rolla VC
PLoS One; 2012; 7(9):e45704. PubMed ID: 23049842
[TBL] [Abstract][Full Text] [Related]
3. Timing of Antiretroviral Treatment, Immunovirologic Status, and TB Risk: Implications for Testing and Treatment.
Pettit AC; Mendes A; Jenkins C; Napravnik S; Freeman A; Shepherd BE; Dowdy D; Gill J; Rachlis A; Moore R; Sterling TR;
J Acquir Immune Defic Syndr; 2016 Aug; 72(5):572-8. PubMed ID: 27049511
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes among HIV/tuberculosis-coinfected patients developing immune reconstitution inflammatory syndrome after HAART initiation in South India.
Kumarasamy N; Venkatesh KK; Vignesh R; Devaleenal B; Poongulali S; Yepthomi T; Flanigan TP; Benson C; Mayer KH
J Int Assoc Provid AIDS Care; 2013; 12(1):28-31. PubMed ID: 23011868
[TBL] [Abstract][Full Text] [Related]
5. Survival of HIV-infected patients after starting tuberculosis treatment: a prospective cohort study.
Maruza M; Albuquerque MF; Braga MC; Barbosa MT; Byington R; Coimbra I; Moura LV; Batista JD; Diniz GT; Miranda-Filho DB; Lacerda HR; Rodrigues LC; Ximenes RA
Int J Tuberc Lung Dis; 2012 May; 16(5):618-24. PubMed ID: 22410415
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological correlates in HIV seropositive tuberculosis cases presenting with jaundice after initiating antiretroviral therapy with a structured review of the literature.
Barr DA; Ramdial PK
BMC Infect Dis; 2012 Oct; 12():257. PubMed ID: 23061403
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous HAART improves survival in children coinfected with HIV and TB.
Pensi T; Hemal A; Banerjee T
Trop Med Int Health; 2012 Jan; 17(1):52-8. PubMed ID: 21967134
[TBL] [Abstract][Full Text] [Related]
8. Immunological profiling of tuberculosis-associated immune reconstitution inflammatory syndrome and non-immune reconstitution inflammatory syndrome death in HIV-infected adults with pulmonary tuberculosis starting antiretroviral therapy: a prospective observational cohort study.
Ravimohan S; Tamuhla N; Steenhoff AP; Letlhogile R; Nfanyana K; Bellamy SL; MacGregor RR; Gross R; Weissman D; Bisson GP
Lancet Infect Dis; 2015 Apr; 15(4):429-38. PubMed ID: 25672566
[TBL] [Abstract][Full Text] [Related]
9. Predictors of mortality among TB-HIV Co-infected patients being treated for tuberculosis in Northwest Ethiopia: a retrospective cohort study.
Sileshi B; Deyessa N; Girma B; Melese M; Suarez P
BMC Infect Dis; 2013 Jul; 13():297. PubMed ID: 23815342
[TBL] [Abstract][Full Text] [Related]
10. Pre-HAART CD4+ T-lymphocytes as biomarkers of post-HAART immune recovery in HIV-infected children with or without TB co-infection.
Gopalakrishnan V; Bose E; Nair U; Cheng Y; Ghebremichael M
BMC Infect Dis; 2020 Oct; 20(1):756. PubMed ID: 33059622
[TBL] [Abstract][Full Text] [Related]
11. A study of TB-associated immune reconstitution inflammatory syndrome using the consensus case-definition.
Sharma SK; Dhooria S; Barwad P; Kadhiravan T; Ranjan S; Miglani S; Gupta D
Indian J Med Res; 2010 Jun; 131():804-8. PubMed ID: 20571170
[TBL] [Abstract][Full Text] [Related]
12. Tuberculosis immune reconstitution inflammatory syndrome in A5221 STRIDE: timing, severity, and implications for HIV-TB programs.
Luetkemeyer AF; Kendall MA; Nyirenda M; Wu X; Ive P; Benson CA; Andersen JW; Swindells S; Sanne IM; Havlir DV; Kumwenda J;
J Acquir Immune Defic Syndr; 2014 Apr; 65(4):423-8. PubMed ID: 24226057
[TBL] [Abstract][Full Text] [Related]
13. Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome after early initiation of antiretroviral therapy in a randomized clinical trial.
Laureillard D; Marcy O; Madec Y; Chea S; Chan S; Borand L; Fernandez M; Prak N; Kim C; Dim B; Nerrienet E; Sok T; Delfraissy JF; Goldfeld AE; Blanc FX;
AIDS; 2013 Oct; 27(16):2577-86. PubMed ID: 24096631
[TBL] [Abstract][Full Text] [Related]
14. Safety and effectiveness of HAART in tuberculosis-HIV co-infected patients in Brazil.
dos Santos AP; Pacheco AG; Staviack A; Golub JE; Chaisson RE; Rolla VC; Kritski AL; Passos SR; de Queiroz Mello FC
Int J Tuberc Lung Dis; 2013 Feb; 17(2):192-7. PubMed ID: 23317954
[TBL] [Abstract][Full Text] [Related]
15. Survival of HIV patients with tuberculosis started on simultaneous or deferred HAART in the THRio cohort, Rio de Janeiro, Brazil.
Saraceni V; Durovni B; Cavalcante SC; Cohn S; Pacheco AG; Moulton LH; Chaisson RE; Golub JE
Braz J Infect Dis; 2014; 18(5):491-5. PubMed ID: 24780362
[TBL] [Abstract][Full Text] [Related]
16. The immune reconstitution inflammatory syndrome after antiretroviral therapy initiation in patients with tuberculosis: findings from the SAPiT trial.
Naidoo K; Yende-Zuma N; Padayatchi N; Naidoo K; Jithoo N; Nair G; Bamber S; Gengiah S; El-Sadr WM; Friedland G; Abdool Karim S
Ann Intern Med; 2012 Sep; 157(5):313-24. PubMed ID: 22944873
[TBL] [Abstract][Full Text] [Related]
17. Risk factors affecting the mortality of HIV-infected patients with pulmonary tuberculosis in the cART era: a retrospective cohort study in China.
Ji YJ; Liang PP; Shen JY; Sun JJ; Yang JY; Chen J; Qi TK; Wang ZY; Song W; Tang Y; Liu L; Zhang RF; Shen YZ; Lu HZ
Infect Dis Poverty; 2018 Mar; 7(1):25. PubMed ID: 29587840
[TBL] [Abstract][Full Text] [Related]
18. Risk factors and frequency of tuberculosis-associated immune reconstitution inflammatory syndrome among HIV/Tuberculosis co-infected patients in Southern India.
Vignesh R; Swathirajan CR; Solomon SS; Shankar EM; Murugavel KG
Indian J Med Microbiol; 2017; 35(2):279-281. PubMed ID: 28681821
[TBL] [Abstract][Full Text] [Related]
19. Clinical spectrum, risk factors and outcome of immune reconstitution inflammatory syndrome in patients with tuberculosis-HIV coinfection.
Worodria W; Menten J; Massinga-Loembe M; Mazakpwe D; Bagenda D; Koole O; Mayanja-Kizza H; Kestens L; Mugerwa R; Reiss P; Colebunders R;
Antivir Ther; 2012; 17(5):841-8. PubMed ID: 22543224
[TBL] [Abstract][Full Text] [Related]
20. Mortality in patients with HIV-1 and tuberculosis co-infection in Rio de Janeiro, Brazil - associated factors and causes of death.
da Silva Escada RO; Velasque L; Ribeiro SR; Cardoso SW; Marins LMS; Grinsztejn E; da Silva Lourenço MC; Grinsztejn B; Veloso VG
BMC Infect Dis; 2017 May; 17(1):373. PubMed ID: 28558689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
